Detalhe da pesquisa
1.
Taste disorders and alopecia in myasthenia gravis.
BMC Neurol;
24(1): 139, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38664714
2.
Markedly upregulated serum semaphorin 4A as a novel activity marker of myasthenia gravis.
Scand J Immunol;
99(5): e13360, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38605547
3.
Clinical features and outcomes of patients with muscle-specific kinase antibody-positive myasthenia gravis in Japan.
J Neuroimmunol;
385: 578241, 2023 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37952282
4.
Serum cytokine profiles in myasthenia gravis with anti-muscle-specific kinase antibodies.
J Neuroimmunol;
384: 578205, 2023 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37774555
5.
Activation of the classical complement pathway in myasthenia gravis with acetylcholine receptor antibodies.
Muscle Nerve;
68(5): 798-804, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37705312
6.
Effects of BL 23 (Shenshu) acupuncture on serum cytokine levels in healthy adults: A randomized double-blind sham-controlled phase 1 study.
J Neuroimmunol;
382: 578165, 2023 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37542799
7.
Role of soluble forms of follicular helper T-cell membrane molecules in the pathogenesis of myasthenia gravis.
J Neuroimmunol;
375: 578014, 2023 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36621075
8.
Impact of Early Treatment with Intravenous High-Dose Methylprednisolone for Ocular Myasthenia Gravis.
Neurotherapeutics;
20(2): 518-523, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36607596
9.
Minimal symptom expression achievement over time in generalized myasthenia gravis.
Acta Neurol Belg;
123(3): 979-982, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36592291
10.
Effectiveness of early cycles of fast-acting treatment in generalised myasthenia gravis.
J Neurol Neurosurg Psychiatry;
94(6): 467-473, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36693723
11.
Time to Pain Relapse After Palliative Radiotherapy for Bone Metastasis: A Prospective Multi-institutional Study.
Anticancer Res;
43(2): 865-873, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36697080
12.
Serum pentraxin 3 concentration correlates with disease severity in patients with myasthenia gravis.
Clin Neurol Neurosurg;
220: 107371, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35878561
13.
Serum cytokine and chemokine profiles in patients with immune-mediated necrotizing myopathy.
J Neuroimmunol;
365: 577833, 2022 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35219938
14.
Immunoadsorption apheresis versus intravenous immunoglobulin therapy for exacerbation of myasthenia gravis.
Scand J Immunol;
95(2): e13122, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34796975
15.
Intrathymic Plasmablasts Are Affected in Patients With Myasthenia Gravis With Active Disease.
Neurol Neuroimmunol Neuroinflamm;
8(6)2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34561276
16.
High levels of serum interleukin-6 are associated with disease activity in myasthenia gravis.
J Neuroimmunol;
358: 577634, 2021 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34174586
17.
High mobility group box 1 is involved in the pathogenesis of passive transfer myasthenia gravis model.
Neuroreport;
32(9): 803-807, 2021 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33994526
18.
Rate of change in acetylcholine receptor antibody levels predicts myasthenia gravis outcome.
J Neurol Neurosurg Psychiatry;
92(9): 963-968, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33766920
19.
Long-term outcomes and prognostic factors in generalized myasthenia gravis.
J Neurol;
268(10): 3781-3788, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33774750
20.
Dispersion of mean consecutive differences in single-fiber electromyography increases diagnostic sensitivity for myasthenia gravis.
Muscle Nerve;
63(6): 885-889, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33748989